About The Event

On Monday, 14 September 2026, the SGLN Biopharma Leaders Programme will bring together leaders from across Singapore’s biopharma ecosystem for our Learning Event, From Molecule to Patient: Leadership in an AI-Enabled Biopharma Ecosystem.

As scientific innovation, AI, geopolitical shifts and changing healthcare needs reshape the industry, our moderated panel, Building an Intelligent and Connected Biopharma Ecosystem: Leadership from Molecule to Patient, will explore how leadership, collaboration and technology can strengthen the journey from molecule to patient.

We are pleased to be joined by three distinguished leaders offering complementary perspectives from across the ecosystem:

• Mr John Graham, Group Chief Executive Officer, Zuellig Pharma
• Mr Koh Liang Hong, Site Head, Modulus, Sanofi Singapore, and Co-Chair, BMAC
• Professor Tan Hiang Khoon, Chief Executive Officer, Singapore General Hospital, and Assistant Group Chief Executive Officer, SingHealth

Together, they represent manufacturing, supply networks and healthcare delivery, spanning the value chain from molecule to patient. Their discussion will explore Singapore’s opportunity within an increasingly interconnected global biopharma landscape, as AI and digital technologies change how organisations operate, connect and make decisions. Drawing on their own leadership experiences, they will reflect on what the next generation of biopharma leaders will need.

The panel will be followed by an open-floor Q&A and an opportunity to connect over drinks with senior leaders from across the SGLN Biopharma ecosystem.

Register your interest here by 1 September 2026

Please note that due to limited seats, registration of interest does not constitute confirmation; successful registrants will receive a separate confirmation from the SGLN team.